References

  1. Knowles NJ, Hovi T, Hyypiä T, King AMQ, Lindberg AM, Pallansch MA, Palmenberg AC, Simmonds P, Skern T, Stanway G, Yamashita T, Zell R. Picornaviridae. In Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses. Edited by King, AMQ, Adams, MJ, Carstens, EB and Lefkowitz, EJ, San Diego. 2012; pp 855-880. Google Scholar

  2. Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172(11):1213-29. PubMed | Google Scholar

  3. Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev. 2000;22(2):298-316. PubMed | Google Scholar

  4. WHA41.28 R. 1988: Global eradication of poliomyelitis by the year 2000. Handbook of resolutions and decisions of the World Health Assembly and the Executive Board. 1988; Vol III, 2nd edition (1985-1989). Google Scholar

  5. Combelas N, Holmblat B, Joffret ML, Colbere-Garapin F, Delpeyroux F. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses. 2011 Aug;3(8):1460-84. PubMed | Google Scholar

  6. Joffret ML, Jegouic S, Bessaud M, Balanant J, Tran C, Caro V et al. Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children. J Infect Dis. 2012;205(9):1363-73. PubMed | Google Scholar

  7. Hagan JE, Wassilak SG, Craig AS, Tangermann RH, Diop OM, Burns CC, et al. Progress toward polio eradication - worldwide, 2014-2015. MMWR Morb Mortal Wkly Rep. 2015;64(19):527-31. PubMed | Google Scholar

  8. WHO. Recommended standards for surveillance of selected vaccine preventable diseases: Vaccines and Biologicals. Geneva: World Health Organization. 2003; pp 31-34. Google Scholar

  9. WHO. Field Guide: For Supplementary Activities aimed at achieving polio eradication, 1996 revision. Geneva, World Health Organization. 1996. Google Scholar

  10. Heymann DL. Polio eradication: finishing the job and protecting the investment. Bull World Health Organ. 2004 Jan;82(1):1. PubMed | Google Scholar

  11. WHO. Assessing the risks for poliovirus outbreaks in polio-free countries-Africa, 2012-2013. MMWR Morb Mortal Wkly Rep. 2013 Sep 20;62(37):768-72. PubMed | Google Scholar

  12. Gumede N, Lentsoane O, Burns CC, Pallansch M, de Gourville E, Yogolelo R et al. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. Emerg Infect Dis. 2013;19(10):1583-9. PubMed | Google Scholar

  13. Gumede N, Jorba J, Deshpande J, Pallansch M, Yogolelo R, Muyembe-Tamfum JJ et al. Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011. J Infect Dis. 2014 Nov 1;210 Suppl 1:S361-7. PubMed | Google Scholar

  14. WHO. Resurgence of wild poliovirus types 1 and 3 in 15 African countries, January 2008-March 2009. Wkly Epidemiol Rec. 2009;84(16):133-40. PubMed | Google Scholar

  15. Anonymous. Plan National de Développent Sanitaire 2011-2015 et données de surveillance 20 Ministry of Health, Democratic Republic of Congo. 2015. PubMed | Google Scholar

  16. Anonymous. Isolation and identification of polioviruses. In: WHO, editor. Polio laboratory manual. Geneva, Switzerland: World Health Organization; 2004. p. 87-100. PubMed | Google Scholar

  17. Anonymous. Intratypic differentiation of polioviruses. In: WHO, editor. Polio laboratory manual. Geneva, Switzerland: World Health Organisation; 2004. p. 101-20. PubMed | Google Scholar

  18. Kilpatrick DR, Ching K, Iber J, Chen Q, Yang SJ, De L et al. Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR. J Virol Methods. 2014;197:25-8. PubMed | Google Scholar

  19. Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L et al. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods. 2011;174(1-2):128-30. PubMed | Google Scholar

  20. World Health Organization. Polio laboratory manual, 4th edition. Geneva: The Organization. WHO/IVB/04.10, 2004. PubMed | Google Scholar

  21. WHO. Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb Mortal Wkly Rep. 2001;50(12):222-4. PubMed | Google Scholar

  22. Hamzat TH, Omotade TT. Acute flaccid paralysis: a five-year review of cases managed by physiotherapy at the University College Hospital, Ibadan. Afr J Health Sci. 2006;13(1-2):28-32. PubMed | Google Scholar

  23. Odoom JK, Ntim NA, Sarkodie B, Addo J, Minta-Asare K, Obodai E et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009-2013. BMC Public Health. 2014;14:687. PubMed | Google Scholar

  24. Singh KKG, Kuma R. Acute paralytic poliomyelitis: change in number over years impact pf PPI: sentinel centre experience. Indian J Community Med. 2004;29:82-3. PubMed | Google Scholar

  25. Mandell GL BJ, Dolin R. Principles and practice of infectious diseases. 5th edition. New York: Churchill Livingston, 2000. PubMed | Google Scholar

  26. D'Errico MM, Barbadoro P, Bacelli S, Esposto E, Moroni V, Scaccia F et al. Surveillance of acute flaccid paralysis in the Marches region (Italy): 1997-2007. BMC Infect Dis. 2008;8(135):1471-2334. PubMed | Google Scholar

  27. Bassey BE, Gasasira A, Mitula P, Frankson UU, Adeniji JA. Surveillance of acute flaccid paralysis in Akwa Ibom State, Nigeria 2004-2009. Pan Afr Med J. 2011;9:32. PubMed | Google Scholar

  28. WHO-UNICEF. Immunization Summary. Report. 2014;Edition 2014. PubMed | Google Scholar

  29. Sevencan F, Ertem M, Oner H, Aras Kilinc E, Kose OO, Demircioglu S et al. Acute flaccid paralysis surveillance in southeastern Turkey, 1999-2010. Turk J Pediatr. 2013;55(3):283-91. PubMed | Google Scholar

  30. Kabue JP, Mushiya F, Pukuta E, Mbaya N, Yogolelo R, Muyamuna E et al. Virological surveillance of acute flaccid paralysis in Democratic Republic of Congo from 1997-2001. Med Trop. 2004;64(2):137-44. PubMed | Google Scholar

  31. Jasem JA, Marof K, Nawar A, Khalaf Y, Al-Hamdani F, Ali S et al. An epidemiological analysis of acute flaccid paralysis and its surveillance system in Iraq, 1997-2011. BMC Infect Dis. 2014;14(448):1471-2334. PubMed | Google Scholar

  32. Rakoto-Andrianarivelo M, Rousset D, Razafindratsimandresy R, Chevaliez S, Guillot S, Balanant J et al. High frequency of human enterovirus species C circulation in Madagascar. Journal of clinical microbiology. 2005 Jan;43(1):242-9. PubMed | Google Scholar

  33. Sadeuh-Mba SA, Bessaud M, Massenet D, Joffret ML, Endegue MC, Njouom R, et al. High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries. J Clin Microbiol. 2013;51(3):759-70. PubMed | Google Scholar

  34. Adu F, Idowu A, Akintokun A, Adeniji J, Ajuwon B. Effect of temperature and distance on the viral outcome of clinical specimens from acute flaccid paralysis cases in Nigeria. J Clin Lab Anal. 2012 Jul;26(4):254-61. PubMed | Google Scholar

  35. Apostol LN, Suzuki A, Bautista A, Galang H, Paladin FJ, Fuji N et al. Detection of non-polio enteroviruses from 17 years of virological surveillance of acute flaccid paralysis in the Philippines. J Med Virol. 2012;84(4):624-31. PubMed | Google Scholar

  36. Dhole TN, Ayyagari A, Chowdhary R, Shakya AK, Shrivastav N, Datta T et al. Non-polio enteroviruses in acute flaccid paralysis children of India: vital assessment before polio eradication. J Paediatr Child Health. 2009;45(7-8):409-13. PubMed | Google Scholar

  37. Lam RM, Tsang TH, Chan KY, Lau YL, Lim WL, Lam TH et al. Surveillance of acute flaccid paralysis in Hong Kong: 1997 to 2002. Hong Kong Med J. 2005;11(3):164-73. PubMed | Google Scholar

  38. Alleman MM, Meyer SA, Mulumba A, Nyembwe M, Riziki Y, Mbule A, et al. Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010-2012. J Infect Dis. 2014 Nov 1;210 Suppl 1:S50-61. PubMed | Google Scholar